Structural requirements for antigen presentation by mouse CD1
about
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptorDiscovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapyMechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT CellsType II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigensCrystal Structures of Bovine CD1d Reveal Altered αGalCer Presentation and a Restricted A’ Pocket Unable to Bind Long-Chain GlycolipidsRecognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptorCD1d expression in paneth cells and rat exocrine pancreas revealed by novel monoclonal antibodies which differentially affect NKT cell activation.DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice.Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1dThe CD1 family and T cell recognition of lipid antigens.Invariant NKT cells are required for airway inflammation induced by environmental antigens.Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.How T lymphocytes recognize lipid antigens.Recognition of CD1d-restricted antigens by natural killer T cells.Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.Glycolipid activators of invariant NKT cells as vaccine adjuvants.MicroRNA-133b Regulation of Th-POK Expression and Dendritic Cell Signals Affect NKT17 Cell Differentiation in the Thymus.Potentiation of murine innate immunity by alpha-galacturonosyl-type glycosphingolipids isolated from Sphingomonas yanoikuyae and S. terrae.Synthesis of a 2"-deoxy-β-GalCerThe length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.The crystal structure of human CD1d with and without alpha-galactosylceramide.Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells.Murine DX5NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4CD62L T Cells through Fas Ligand
P2860
Q24672186-331921AF-4252-4C21-963F-D6B714418F56Q26801584-D50A5DD1-E8A4-46A4-A369-3D4164D3E282Q27658388-9E599CFC-3A14-4819-B35D-944FAA95E9EDQ27670856-6753E25E-39EC-43AA-A4DA-47072501F86AQ27674794-E78F3E2B-E5D9-4CC8-A1D9-633783DF3C9CQ27681807-47121B3D-1E5F-44D6-A808-512211A1D4A5Q33711991-90770052-627A-46EA-B852-E758424F1559Q33884869-392F8BB5-416B-4933-A01F-24F4066AB524Q33947957-46D2EA75-34B0-46CA-BAD3-4D964348831DQ34572848-16D657C2-122D-40E9-94A8-1F68EDE913F7Q35030902-1D0812D6-3B05-4722-871F-3486F94C46A6Q35213600-C75FD8FD-B148-4106-B908-2729031A72C2Q35798146-84C0F444-B60B-420B-8B69-9465609A4442Q36228456-77866D6B-7B05-4D08-83A7-95F5AB691861Q36228473-4A5D6AA4-505E-4CF9-8256-129A547FA4BBQ36537962-9389F2C8-BDD1-4E8F-A55F-8A5388761C3AQ36584187-DC091E39-1BF0-40E7-A750-C9B3F1C99A83Q37088000-C98E804E-3671-4F43-BA1B-1C6020086CF2Q37100905-48C62DAB-7690-4A60-962E-4818D509E9A5Q37484801-BBD9A66E-21BF-4395-BB24-CDCFD67E901FQ38885794-646C72A4-2C4F-4A81-8570-A6E7D125E31DQ39412748-E511D1F0-0C5C-4FC9-9C3F-6C17B46E2434Q39833305-C888A94C-7E65-4C6B-B307-876B1681B892Q39958212-D6C2FE8E-80ED-4EF3-8992-6B2AC1302298Q40136032-36D7DD49-E5E9-48D0-A123-11F6EDD6A91AQ40406927-00694170-83F9-4295-9490-DB2C39F7DD6AQ40545660-797CECC0-5BC1-4114-86CE-0B89F0A5013BQ42661990-36BFB923-19A9-4200-809E-25AFA38A7F72Q43093958-B322C01A-523B-46BE-83F6-14AC8E0B7BA7Q43432096-124FB32B-0C68-4B1B-9AEB-E6E5DA8CF49DQ46251286-C6AD611C-5F51-4890-8378-38E8448AC9C8Q58604257-70606941-99A5-4C8E-9C21-7C106F3768F6
P2860
Structural requirements for antigen presentation by mouse CD1
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Structural requirements for antigen presentation by mouse CD1
@en
Structural requirements for antigen presentation by mouse CD1.
@nl
type
label
Structural requirements for antigen presentation by mouse CD1
@en
Structural requirements for antigen presentation by mouse CD1.
@nl
prefLabel
Structural requirements for antigen presentation by mouse CD1
@en
Structural requirements for antigen presentation by mouse CD1.
@nl
P2093
P2860
P356
P1476
Structural requirements for antigen presentation by mouse CD1
@en
P2093
P2860
P304
10156-10161
P356
10.1073/PNAS.97.18.10156
P407
P577
2000-08-01T00:00:00Z